Literature DB >> 28701102

Mechanism of action of mRNA-based vaccines.

Carlo Iavarone1, Derek T O'hagan1, Dong Yu1, Nicolas F Delahaye1, Jeffrey B Ulmer1.   

Abstract

INTRODUCTION: The present review summarizes the growing body of work defining the mechanisms of action of this exciting new vaccine technology that should allow rational approaches in the design of next generation mRNA vaccines. Areas covered: Bio-distribution of mRNA, localization of antigen production, role of the innate immunity, priming of the adaptive immune response, route of administration and effects of mRNA delivery systems. Expert commentary: In the last few years, the development of RNA vaccines had a fast growth, the rising number of proof will enable rational approaches to improving the effectiveness and safety of this modern class of medicine.

Keywords:  Intrinsic adjuvanticity; antiviral response; delivery system; innate immunity; optimization; self-amplifying mRNA (SAM); type I interferon

Mesh:

Substances:

Year:  2017        PMID: 28701102     DOI: 10.1080/14760584.2017.1355245

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  53 in total

Review 1.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

Review 2.  mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

Authors:  Giulietta Maruggi; Cuiling Zhang; Junwei Li; Jeffrey B Ulmer; Dong Yu
Journal:  Mol Ther       Date:  2019-02-07       Impact factor: 11.454

Review 3.  Comparison of DNA and mRNA vaccines against cancer.

Authors:  Zohreh Jahanafrooz; Behzad Baradaran; Jafar Mosafer; Mahmoud Hashemzaei; Tayebeh Rezaei; Ahad Mokhtarzadeh; Michael R Hamblin
Journal:  Drug Discov Today       Date:  2019-12-13       Impact factor: 7.851

4.  A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity.

Authors:  Tim Beissert; Mario Perkovic; Annette Vogel; Stephanie Erbar; Kerstin C Walzer; Tina Hempel; Silke Brill; Erik Haefner; René Becker; Özlem Türeci; Ugur Sahin
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

5.  Formulation and Delivery Technologies for mRNA Vaccines.

Authors:  Chunxi Zeng; Chengxiang Zhang; Patrick G Walker; Yizhou Dong
Journal:  Curr Top Microbiol Immunol       Date:  2020-06-02       Impact factor: 4.291

6.  Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.

Authors:  Marcelo M Samsa; Lesley C Dupuy; Clayton W Beard; Carolyn M Six; Connie S Schmaljohn; Peter W Mason; Andrew J Geall; Jeffrey B Ulmer; Dong Yu
Journal:  Mol Ther       Date:  2019-01-07       Impact factor: 11.454

Review 7.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 8.  Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

Authors:  Yinan Xiao; Hanyue Xu; Wen Guo; Yunuo Zhao; Yuling Luo; Ming Wang; Zhiyao He; Zhenyu Ding; Jiyan Liu; Lei Deng; Fushen Sha; Xuelei Ma
Journal:  Mol Biomed       Date:  2020-12-03

Review 9.  Exploiting vita-PAMPs in vaccines.

Authors:  J Magarian Blander; Gaetan Barbet
Journal:  Curr Opin Pharmacol       Date:  2018-06-08       Impact factor: 5.547

Review 10.  Strategies to deliver RNA by nanoparticles for therapeutic potential.

Authors:  Alysia Cox; Siyoung A Lim; Eun Ji Chung
Journal:  Mol Aspects Med       Date:  2021-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.